Abstract
The present study was undertaken to develop an agent that stabilizes insulin injected subcutaneously. 125I-Porcine insulin with 0.2 U/kg unlabeled porcine insulin was subcutaneously injected with or without collagen in the rat under the depilated skin of the back. At various times, the radioactivity in subcutaneous tissue was assayed for insulin and its metabolites by gel filtration. The degradation and absorption rate constants of insulin at the subcutaneous injection site were estimated according to a one-compartment model. The degradation rate constant of insulin in the presence of collagen at the injection site was less than half of the control rate. The inhibition was confirmed by increases in the immunoreactive insulin plasma levels and the hypoglycemic effect in rats and healthy volunteers. We postulate that collagen prevents insulin from being degraded by inhibiting proteolytic enzymes, mainly collagenase-like peptidase, in subcutaneous tissue.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
M. Berger, P. A. Halbon, W. A. Muller, R. E. Offord, A. E. Renold, and M. Vranic. Diabetologia 15:133–140 (1978).
R. W. Stevenson, T. I. Tsakok, and J. A. Parsons. Diabetologia 18:423–426 (1980).
R. Hori, F. Komada, and K. Okumura. J. Pharm. Sci. 72:435–439 (1983).
M. Berger, P. A. Halbon, L. Girardier, J. Seydoux, R. E. Offord, and A. E. Renold. Diabetologia 17:97–99 (1979).
S. M. O. Guerra and A. E. Kitabchi. J. Clin. Endocrinol. Metab. 42:869–874 (1976).
T. Kobayashi, S. Sawano, T. Itho, K. Kosaka, H. Hirayama, and Y. Kasuya. Diabetes 32:331–336 (1983).
F. Komada, K. Okumura, and R. Hori. J. Pharmacobio-Dyn. 8:33–40 (1985).
A. L. Rubin, K. H. Stenzel, T. Miyata, M. J. White, and M. Dunn. J. Clin. Pharmacol. 13:309–312 (1973).
K. H. Stenzel, J. F. Sullivan, T. Miyata, and A. L. Rubin. Trans. Am. Soc. Artif. Intern. Organs 15:114–117 (1969).
K. H. Stenzel, T. Miyata, and A. L. Rubin. Annu. Rev. Biophys. Bioeng. 3:231–253 (1974).
P. Freychet, J. Roth, and D. M. Neville Jr. Biochem. Biophys. Res. Commun. 43:400–408 (1971).
K. Okumura, F. Komada, and R. Hori. J. Pharmacobio-Dyn. 8:25–32 (1985).
C. N. Hales and P. J. Randle. Biochem. J. 88:137–146 (1963).
A. Hyvärinen and E. A. Nikkilä. Clin. Chim. Acta 7:140–143 (1962).
A. Junod, A. E. Lambert, W. Stauffacher, and A. E. Renold. J. Clin. Invest. 48:2129–2139 (1969).
R. Hori, Y. Saito, M. Yasuhara, and K. Okumura. J. Pharmacobio-Dyn. 7:910–916 (1984).
M. Gibaldi and D. Perrier. In J. Swarbrick (ed.), Drug and the Pharmaceutical Sciences, Vol. I, Pharmacokinetics, Marcel Dekker, New York, 1975, pp. 1–27.
T. Nakagawa, Y. Koyanagi, and H. Togawa. SALS, Library Program of the University of Tokyo Computer Center, Tokyo (1975).
R. E. Chipkin, W. Kreutner, and W. Billard. Eur. J. Pharmacol. 102:151–154 (1984).
B. Malfloy and J. C. Schwartz. Biochem. Biophys. Res. Commun. 106:276–285 (1982).
G. Williams, J. C. Pickup, S. Bowcock, E. Cook, and H. Keen. Diabetologia 24:91–94 (1983).
M. Berger, H. J. Cüppers, P. A. Halban, and R. E. Offerd. Diabetes 29:81–83 (1983).
W. Lorenz, A. Doenicke, K. Messmer, H. J. Reimann, M. Thermann, W. Lahn, J. Berr, A. Schmal, P. Dormann, P. Regenfuss, and H. Hamelmann. Br. J. Anaesth. 48:151–164 (1976).
A. Doenicke, B. Grote, and W. Lorenz. Br. J. Anaesth. 49:681–688 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hori, R., Komada, F., Iwakawa, S. et al. Enhanced Bioavailability of Subcutaneously Injected Insulin Coadministered with Collagen in Rats and Humans. Pharm Res 6, 813–816 (1989). https://doi.org/10.1023/A:1015987800808
Issue Date:
DOI: https://doi.org/10.1023/A:1015987800808